Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin

Cancer Chemotherapy and Pharmacology

Volumn 62, Issue 4, 2008, Pages 559-568

  Ma, Rundi ^a   Song, Gang ^a   You, Wenbing ^a   Yu, Lijian ^a   Su, Weiming ^a   Liao, Mingneng ^a   Zhang, Yongping ^a   Huang, Laizhen ^a   Zhang, Xiaoyu ^a,c   Yu, Tingxi ^a,b  

^a GUANGDONG OCEAN UNIVERSITY   (China)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Anti microtubule activity; Bolbostemma paniculatum (Maxim.) Franquet; Colchicine binding site of tubulin; Tubeimoside I; Uptake kinetics

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; BETA ACTIN; BUFFER; COLCHICINE; MICROTUBULE PROTEIN; PACLITAXEL; TUBEIMOSIDE I; TUBULIN; VINBLASTINE;

ARTICLE; BINDING COMPETITION; CANCER CELL CULTURE; CANCER INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DEPOLYMERIZATION; DRUG BINDING SITE; DRUG DETERMINATION; DRUG PROTEIN BINDING; DRUG TUMOR LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC 50; IMMUNOBLOTTING; IMMUNOELECTRON MICROSCOPY; LIGAND BINDING; MICROTUBULE ASSEMBLY; POLYMERIZATION; PRIORITY JOURNAL; SEDIMENTATION; STRUCTURE ACTIVITY RELATION; TIME; TURBIDITY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BINDING SITES; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLCHICINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; HUMANS; MICROTUBULE PROTEINS; NASOPHARYNGEAL NEOPLASMS; POLYMERS; SAPONINS; SWINE; TRITERPENES; TUBULIN; TUBULIN MODULATORS;

EID: 41449116518     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-007-0635-0     Document Type: Article

References (38)

1. Zhao XM (1983) Supplement to the compendium of materia medica (reprinted from the 1765 wood-engraved edition). The People's Medical Publishing House, Beijing, p 123
2. YQ Wang LJ Yu JL Zhu SY Yang 1981 Studies on antitumor action of extracts of Bolbostemma paniculatum (Maxim.) Franquet Shaanxi Med J 10 55
3. F Kong D Zhu R Xu Z Fu L Zhou T Iwashita H Komura 1986 Structural study of TBMS1, a constituent of tu-bei-mo Tetrahedron Lett 27 5765
4. LJ Yu RD Ma YQ Wang H Nishino 1994 Potent anti-tumor activity and low toxicity of tubeimoside I isolated from Bolbostemma paniculatum Planta Med 60 204
5. LJ Yu RD Ma YQ Wang H Nishino J Takayasu WZ He M Chang J Zhen WS Liu SX Fan 1992 Potent anti-tumorigenic effect of tubeimoside I isolated from the bulb of Bolbostemma paniculatum (Maxim.) Franquet Int J Cancer 50 635
6. LJ Yu RD Ma TX Yu 1996 Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL-60) by tubeimoside I Planta Med 62 119
7. CX Wang RD Ma LJ Yu 2006 Inhibitory effects of tubeimoside I, a cyclic bisdesmoside isolated from Bolbostemma paniculatum, on metastases of mouse B16 melonoma and lewis lung carcinoma Chin J Clin Pharmacol Ther 11 764
8. Z Hu RD Ma LJ Yu 2003 Effects of tubeimoside I on cell cycle and apoptosis of human myeloblastic leukemia cells (HL-60) Chin J Clin Oncol 30 163
9. RD Ma LJ Yu WM Su HY Shao MN Liao DM He LZ Huang 2004 Induction of cell cycle arrest and apoptosis by tubeimoside I isolated from Bolbostemma paniculatum in HeLa cells Chin J Clin Pharmacol Ther 9 261
10. RD Ma XY Weng LJ Yu WM Su HY Shao MN Liao DM He LZ Huang TX Yu 2003 Apoptosis of human nasopharyngeal carcinoma CNE-2Z cell line induced by tubeimoside I isolated from Bolbostemma paniculatum U S Chin J Limph Ocol 2 11
11. PB Schiff SB Horwitz 1980 Taxol stabilizes microtubules in mouse fibroblast cells Proc Natl Acad Sci USA 77 1561
12. EK Rowinsky 1997 The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents Annu Rev Med 48 353
13. A Jordan JA Hadfield NJ Lawrence AT McGown 1998 Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle Med Res Rev 18 259
14. Q Li H Sham S Rosenberg 1999 Antimitotic agents Annu Rep Med Chem 34 139
15. F. RD Wang Ma LJ Yu 2006 Role of mitochondria and mitochondrial cytochrome C in tubeimoside I-mediated apoptosis of human cervical carcinoma HeLa cell line Cancer Chemother Pharmacol 57 389
16. DH Hu RD Ma LJ Yu 2003 Inhibition of angiogenesis by tubeimoside I Chin Pharmacol Bull 19 715
17. N Klauber S Parangi E Flynn E Hamel RJ D'Amato 1997 Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol Cancer Res 57 81
18. SY Gu WP Zhao Y Zeng WP Tang ML Zhao HH Deng 1983 An epithelial cell line established from poorly differentiated nasopharyngeal carcinoma Chin J Cancer 2 70
19. MB Hansen SE Nielsen K Berq 1989 Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill J Immunol Methods 119 203
20. YL Wei XM Yang CG Xu H Gao WJ Sun 2000 Quantitation of tubeimoside I by HPLC Northwest J Pharm 15 107
21. M Castoldi AV Popov 2003 Purification of brain tubulin through two cycles of polymerization-depolymerization in a high-molarity buffer Protein Expr Purif 32 83
22. OH Lowry NJ Rosebrough AL Farr RJ Randall 1951 Protein measurement with the Folin phenol reagent J Biol Chem 193 265
23. JM Mínguez SY Kim KA Giuliano R Balachandran C Madiraju BW Day DP Curran 2003 Synthesis and biological assessment of simplified analogues of the potent microtubule stabilizer (+)-discodermolide Bioorg Med Chem 11 3335
24. M Mitsui-Saito S Ohkubo Y Obara T Yanagisawa J Kobayashi Y Ohizumi N Nakahata 2002 Theonezolide A, a novel marine macrolide, induces drastic shape change in rabbit platelets by reorganization of microtubules Thromb Res 108 133
25. RA Isbrucker J Cummins SA Pomponi RE Longley AE Wright 2003 Tubulin polymerizing activity of dictyostatin-1, a polyketide of marine sponge origin Biochem Pharmacol 66 75
26. M Kavallaris AS Tait BJ Walsh L He SB Horwitz MD Norris M Haber 2001 Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells Cancer Res 61 5803
27. RL Bai GR Pettit E Hamel 1990 Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinka alkaloid sites J Biol Chem 265 17141
28. MC Edler AM Fernandez P Lassota CM Ireland LR Barrows 2002 Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin 10 Biochem Pharmacol 63 707
29. J Nunez A Fellous J Francon AM Lennon 1979 Competitive inhibition of colchicine binding to tubulin by microtubule-associated proteins Proc Natl Acad Sci USA 76 86
30. RJ D'Amato CM Lin E Flynn J Folkman E Hamel 1994 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site Proc Natl Acad Sci USA 91 3964
31. Dixon M, Webb EC, Thorne CJR, Tipton KF (1979) Enzymes. Academic, New York, p 332
32. TL Tinley RM Leal DA Randall-Hlubek JW Cessac LR Wilkens PN Rao SL Mooberry 2003 Novel 2-methoxyestradiol analogues with antitumor activity Cancer Res 63 1538
33. TL Tinley DA Randall-Hlubek RM Leal EM Jackson JW Cessac JC Quada Jr TK Hemscheidt SL Mooberry 2003 Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity Cancer Res 63 3211
34. J Kobyashi H Suzuki K Shimbo K Takeya H Morita 2001 Celogentins A-C, new antimitotic bicyclic peptides from the seeds of Celosia argentea J Org Chem 66 6626
35. M Cushman HM He CM Lin E Hamel 1993 Synthesis and evaluation of a series of benzylaniline hydrochlorides as potential cytotoxic and antimitotic agents acting by inhibition of tubulin polymerization J Med Chem 36 2817
36. R Bai GR Pettit E Hamel 1990 Dolastatin 10, a powerful cytostatic peptide derived from a marine animal: inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain Biochem Pharmacol 39 1941
37. R Bai SJ Friedman GR Pettit E Hamel 1992 Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia: interactions with tubulin and effects on cellular microtubules Biochem Pharmacol 43 2637
38. JP Dutcher Y Novik K O'Boyle G Marcoullis C Secco PH Wiernik 2000 20th-century advance in drug therapy in oncology-Part II J Clin Pharmacol 40 1079